These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 31151050

  • 1. Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1.
    Estève J, Blouin JM, Lalanne M, Azzi-Martin L, Dubus P, Bidet A, Harambat J, Llanas B, Moranvillier I, Bedel A, Moreau-Gaudry F, Richard E.
    Stem Cell Res; 2019 Jul; 38():101467. PubMed ID: 31151050
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1.
    Castello R, Borzone R, D'Aria S, Annunziata P, Piccolo P, Brunetti-Pierri N.
    Gene Ther; 2016 Feb; 23(2):129-34. PubMed ID: 26609667
    [Abstract] [Full Text] [Related]

  • 4. Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT gene.
    Martinez-Turrillas R, Rodriguez-Diaz S, Rodriguez-Marquez P, Martin-Mallo A, Salido E, Beck BB, Prosper F, Rodriguez-Madoz JR.
    Stem Cell Res; 2019 Dec; 41():101626. PubMed ID: 31715429
    [Abstract] [Full Text] [Related]

  • 5. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
    Kukreja A, Lasaro M, Cobaugh C, Forbes C, Tang JP, Gao X, Martin-Higueras C, Pey AL, Salido E, Sobolov S, Subramanian RR.
    Nucleic Acid Ther; 2019 Apr; 29(2):104-113. PubMed ID: 30676254
    [Abstract] [Full Text] [Related]

  • 6. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
    Oppici E, Roncador A, Montioli R, Bianconi S, Cellini B.
    Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
    [Abstract] [Full Text] [Related]

  • 7. Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1.
    Jiang J, Salido EC, Guha C, Wang X, Moitra R, Liu L, Roy-Chowdhury J, Roy-Chowdhury N.
    Transplantation; 2008 May 15; 85(9):1253-60. PubMed ID: 18475180
    [Abstract] [Full Text] [Related]

  • 8. Cellular transfection to deliver alanine-glyoxylate aminotransferase to hepatocytes: a rational gene therapy for primary hyperoxaluria-1 (PH-1).
    Koul S, Johnson T, Pramanik S, Koul H.
    Am J Nephrol; 2005 May 15; 25(2):176-82. PubMed ID: 15849465
    [Abstract] [Full Text] [Related]

  • 9. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.
    Fargue S, Knight J, Holmes RP, Rumsby G, Danpure CJ.
    Biochim Biophys Acta; 2016 Jun 15; 1862(6):1055-62. PubMed ID: 26854734
    [Abstract] [Full Text] [Related]

  • 10. Molecular etiology of primary hyperoxaluria type 1: new directions for treatment.
    Danpure CJ.
    Am J Nephrol; 2005 Jun 15; 25(3):303-10. PubMed ID: 15961951
    [Abstract] [Full Text] [Related]

  • 11. Molecular aetiology of primary hyperoxaluria type 1.
    Danpure CJ.
    Nephron Exp Nephrol; 2004 Jun 15; 98(2):e39-44. PubMed ID: 15499210
    [Abstract] [Full Text] [Related]

  • 12. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
    Danpure CJ.
    Biochim Biophys Acta; 2006 Dec 15; 1763(12):1776-84. PubMed ID: 17027096
    [Abstract] [Full Text] [Related]

  • 13. Combined liver-kidney transplantation in primary hyperoxaluria type 1.
    Cochat P, Gaulier JM, Koch Nogueira PC, Feber J, Jamieson NV, Rolland MO, Divry P, Bozon D, Dubourg L.
    Eur J Pediatr; 1999 Dec 15; 158 Suppl 2():S75-80. PubMed ID: 10603104
    [Abstract] [Full Text] [Related]

  • 14. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
    van Woerden CS, Groothof JW, Wanders RJ, Waterham HR, Wijburg FR.
    Ned Tijdschr Geneeskd; 2006 Jul 29; 150(30):1669-72. PubMed ID: 16922352
    [Abstract] [Full Text] [Related]

  • 15. In vivo base editing rescues primary hyperoxaluria type 1 in rats.
    Chen Z, Zhang D, Zheng R, Yang L, Huo Y, Zhang D, Fang X, Li Y, Xu G, Li D, Geng H.
    Kidney Int; 2024 Mar 29; 105(3):496-507. PubMed ID: 38142039
    [Abstract] [Full Text] [Related]

  • 16. Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1.
    Danpure CJ, Jennings PR.
    Clin Sci (Lond); 1988 Sep 29; 75(3):315-22. PubMed ID: 3416563
    [Abstract] [Full Text] [Related]

  • 17. Immunocytochemical localization of human hepatic alanine: glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type 1.
    Cooper PJ, Danpure CJ, Wise PJ, Guttridge KM.
    J Histochem Cytochem; 1988 Oct 29; 36(10):1285-94. PubMed ID: 3418107
    [Abstract] [Full Text] [Related]

  • 18. Natural and Unnatural Compounds Rescue Folding Defects of Human Alanine: Glyoxylate Aminotransferase Leading to Primary Hyperoxaluria Type I.
    Oppici E, Montioli R, Dindo M, Cellini B.
    Curr Drug Targets; 2016 Oct 29; 17(13):1482-91. PubMed ID: 26931357
    [Abstract] [Full Text] [Related]

  • 19. The ILE56 mutation on different genetic backgrounds of alanine:glyoxylate aminotransferase: Clinical features and biochemical characterization.
    Dindo M, Mandrile G, Conter C, Montone R, Giachino D, Pelle A, Costantini C, Cellini B.
    Mol Genet Metab; 2020 Oct 29; 131(1-2):171-180. PubMed ID: 32792227
    [Abstract] [Full Text] [Related]

  • 20. Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation.
    Zapata-Linares N, Rodriguez S, Salido E, Abizanda G, Iglesias E, Prosper F, Gonzalez-Aseguinolaza G, Rodriguez-Madoz JR.
    Stem Cell Res; 2016 Jan 29; 16(1):116-9. PubMed ID: 27345794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.